Sep 29, 2022
Newsletter
All News
Sep 27, 2022
Blog
Critical Communications Around SPAC Liquidation and De-Listing
By Phil Denning
Sep 26, 2022
Blog
The ‘Innovator’s Burden’: How to combat skepticism in healthcare as a first-of-its-kind company
By
Sep 21, 2022
Podcast
Episode 45: Flywheeling High: Creating a Niche in Private Markets Investment with Scott Hart, StepStone Group
By Thomas M. Ryan
Sep 20, 2022
Blog
What the SEC Pay-for-Performance Rules Mean for Proxy 2023
By
Sep 19, 2022
Newsletter
ICR D.C. Insider: September 2022
By ICR
Sep 15, 2022
Blog
Turning the Tables on Corporate Access
By Meaghan Montegari
Sep 14, 2022
Podcast
Episode 44: ICR Industry Reports #6: Investor Access with Meaghan Montegari, Managing Director at ICR
By Thomas M. Ryan
Sep 7, 2022
Blog
5 Benefits of Proper Earnings Call Preparation
By ICR
Sep 7, 2022
Blog
The Evolution of ESG: Current and Future Trends
By ICR
Sep 7, 2022
Podcast
Episode 43: Investing in Your IP Strategy: The Importance of Protecting Your Intellectual Property with John Mancini, Mayer Brown
By Thomas M. Ryan
Aug 31, 2022
Podcast
Episode 42: On Firm Footing: How Law Firms Play an Essential Role in the Corporate Landscape with Henry Nassau, Dechert
By Thomas M. Ryan
Aug 30, 2022
Blog
Analyst Day Best Practices: 24 Things You Need to Know
By ICR Team
Aug 24, 2022
News & Press
ICR Launches SPAC Liquidation Communications Services
By ICR
Aug 24, 2022
Podcast
Episode 41: The Data on Distrust: Building and Maintaining Trust as a Leader with Joe Folkman, Zenger Folkman
By Thomas M. Ryan
Aug 23, 2022
Blog
Is the Biotech IPO Market Coming Back? How to Prepare
By Kate Coyle- < Previous posts
- 01
- …
- 28
- 29
- 30
- 31
- 32
- …
- 76
- > Next posts